EVMN
Evommune, Inc.
6.90$
-4.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +19.9% | +1.8% | +8.8% | +4.7% | -0.5% | -17.1% | +4.8% | +7.1% | +58.2% | – | |
| – | – | – | +22.9% | – | – | – | +649.3% | -17.7% | +33.1% | – | |
| – | – | -158.0% | – | -651.7% | – | – | +207.9% | -215.8% | – | – | |
| – | -74.3% | -100.0% | – | – | – | – | -20.6% | -20.2% | +120.5% | – | |
| – | +3.9% | – | – | – | +33.3% | -232.8% | +414.1% | -30.5% | – | – | |
| – | – | – | +42.4% | – | – | – | -9.5% | +1.2% | +63.2% | – | |
| – | +80.0% | +5.6% | – | -100.3% | – | -100.4% | – | -25.3% | -99.5% | – | |
| – | -96.2% | -1,409.3% | – | – | +884.1% | -162.4% | – | -75.3% | +170.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.